Trials of DVT pill a success
Trials of the first pill developed specifically for the treatment of deep vein thrombosis (DVT) have been a success, according to the company making the treatment.
The newly-developed Flite Tab helps to prevent DVT by having an anticoagulant effect on the blood, and an anti-inflammatory effect on the blood vessels; at present the only recommended measures to guard against the condition are to take an aspirin, to wear compression stockings, and to drink water and exercise during flights.
The study to measure the effectiveness of the new Flite Tabs involved 186 volunteers who were at moderate risk of DVT, on a flight from London to New York; 94 took the new tablet while 92 received a placebo. Of the placebo group, seven had blood clots; in the Flite Tab group, none had blood clots.
According to the Daily Mail, Professor Gianni Belcaro, who carried out the study, said: “Our study shows Flite Tabs were effective in reducing the incidence of DVT. They are far more effective than aspirin. In fact, we have done a study on aspirin and have found it to be almost entirely ineffective in preventing DVT. Besides, one third of people can’t take it.”
For more details visit www.flitetabs.co.uk.
Have your say Cancel reply
Subscribe/Login to Travel Mole Newsletter
Travel Mole Newsletter is a subscriber only travel trade news publication. If you are receiving this message, simply enter your email address to sign in or register if you are not. In order to display the B2B travel content that meets your business needs, we need to know who are and what are your business needs. ITR is free to our subscribers.































France prepares for a massive strike across all transports on September 18
Turkish tourism stalls due to soaring prices for accommodation and food
CCS Insight: eSIMs ready to take the travel world by storm
Germany new European Entry/Exit System limited to a single airport on October 12, 2025
Airlines suspend Madagascar services following unrest and army revolt